- Home
- EDSA vs ANGH Comparison
EDSA vs ANGH Comparison
Compare EDSA & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- ANGH
- Stock Information
- Founded
- EDSA 2015
- ANGH 2012
- Country
- EDSA Canada
- ANGH United Arab Emirates
- Employees
- EDSA N/A
- ANGH N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- ANGH Telecommunications Equipment
- Sector
- EDSA Health Care
- ANGH Consumer Discretionary
- Exchange
- EDSA Nasdaq
- ANGH Nasdaq
- Market Cap
- EDSA 18.6M
- ANGH 19.1M
- IPO Year
- EDSA N/A
- ANGH N/A
- Fundamental
- Price
- EDSA $2.66
- ANGH $2.76
- Analyst Decision
- EDSA Strong Buy
- ANGH
- Analyst Count
- EDSA 2
- ANGH 0
- Target Price
- EDSA $13.00
- ANGH N/A
- AVG Volume (30 Days)
- EDSA 140.8K
- ANGH 7.1K
- Earning Date
- EDSA 12-12-2025
- ANGH 11-04-2025
- Dividend Yield
- EDSA N/A
- ANGH N/A
- EPS Growth
- EDSA N/A
- ANGH N/A
- EPS
- EDSA N/A
- ANGH N/A
- Revenue
- EDSA N/A
- ANGH $78,093,405.00
- Revenue This Year
- EDSA N/A
- ANGH N/A
- Revenue Next Year
- EDSA N/A
- ANGH N/A
- P/E Ratio
- EDSA N/A
- ANGH N/A
- Revenue Growth
- EDSA N/A
- ANGH 88.72
- 52 Week Low
- EDSA $1.55
- ANGH $2.53
- 52 Week High
- EDSA $4.49
- ANGH $9.40
- Technical
- Relative Strength Index (RSI)
- EDSA 54.92
- ANGH 40.79
- Support Level
- EDSA $2.42
- ANGH $2.75
- Resistance Level
- EDSA $2.95
- ANGH $2.94
- Average True Range (ATR)
- EDSA 0.21
- ANGH 0.11
- MACD
- EDSA 0.01
- ANGH -0.01
- Stochastic Oscillator
- EDSA 49.86
- ANGH 39.94
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.